Scarica l'app Stockscreener
1.31
2.96%
-0.04
Dopo l'orario di chiusura:
1.30
-0.01
-0.76%
Precedente Chiudi:
$1.35
Aprire:
$1.35
Volume 24 ore:
68,422
Relative Volume:
0.04
Capitalizzazione di mercato:
$11.76M
Reddito:
$5.64M
Utile/perdita netta:
$-23.88M
Rapporto P/E:
-2.4717
EPS:
-0.53
Flusso di cassa netto:
$-22.36M
1 W Prestazione:
-0.76%
1M Prestazione:
-3.68%
6M Prestazione:
-21.08%
1 anno Prestazione:
-72.93%
Intervallo 1D:
$1.28
$1.35
Intervallo di 1 settimana:
$1.28
$1.36
Portata 52W:
$0.95
$5.695
Evogene Ltd Stock (EVGN) Company Profile
Confronta EVGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.31 | 11.76M | 5.64M | -23.88M | -22.36M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-08 | Iniziato | ROTH Capital | Buy |
| 2021-07-29 | Iniziato | Aegis Capital | Buy |
| 2020-12-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Iniziato | Oppenheimer | Outperform |
Evogene Ltd Borsa (EVGN) Ultime notizie
How many analysts rate Evogene Ltd. as a “Buy”Invest smarter with actionable stock recommendations - jammulinksnews.com
Why is Evogene Ltd. stock attracting strong analyst attentionPhenomenal capital gains - jammulinksnews.com
How does Evogene Ltd. compare to its industry peersCapitalize on market opportunities with confidence - jammulinksnews.com
Does Evogene Ltd. stock perform well during market downturnsCapitalize on market trends with confidence - jammulinksnews.com
Should I hold or sell Evogene Ltd. stock in 2025Superior risk-adjusted returns - jammulinksnews.com
What markets is EYEN expanding into Is Evogene Ltd. stock a good long term investment option - jammulinksnews.com
Is Evogene Ltd. stock overvalued or undervaluedOutstanding yields - jammulinksnews.com
What risks could impact Evogene Ltd. stock performanceRisk Managed Trading Strategy - Metal.it
Why Evogene Ltd. stock attracts strong analyst attentionFree Predictions - Metal.it
Is Evogene Ltd. a good long term investmentRemarkable growth - PrintWeekIndia
Evogene Ltd. Stock Analysis and ForecastExplosive earning power - PrintWeekIndia
How Evogene Ltd. stock reacts to Fed policy changesRecord-setting profit potential - jammulinksnews.com
What drives Evogene Ltd. stock priceExceptional trading results - PrintWeekIndia
What analysts say about Evogene Ltd. stockRemarkably fast returns - jammulinksnews.com
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting - global-agriculture.com
How Evogene Ltd. stock compares to its top competitorsIs SBCF stock undervalued or overvalued nowFree Daily Stock Market Updates - Newser
Evogene Updates Proxy Card for August 2025 Shareholder Meeting - TipRanks
What makes Evogene Ltd. stock price move sharplyHigh Return Potential - Newser
How Evogene Ltd. stock performs during market volatilityChart Based Entries - Newser
Biomica Announces Closing of $20 Million Financing Round led by Shanghai Healthcare Capital - global-agriculture.com
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer - global-agriculture.com
Evogene Completes Sale of Lavie Bio’s Activities to ICL - The Globe and Mail
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activity to ICL - global-agriculture.com
ICL Finalizes Acquisition of AI-Driven Ag Tech Company Lavie Bio - AgriBusiness Global
EVGN closes Lavie Bio sale to ICL; financial terms undisclosed | UHG SEC FilingForm 8-K - Stock Titan
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL - Nasdaq
Agricultural Biotechnology Market Outlook Report to 2030, with Profiles of Bayer, Corteva, Syngenta, BASF, FMC, Bioceres Crop Solutions, Evogene, Marrone Bio Innovations, Calyxt & Arcadia Biosciences - GlobeNewswire
Evogene Ltd Azioni (EVGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):